ET-blockade and Exercise Induced Blood Flow in T2DM

NCT01779596 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Bosentan
DRUG: Placebo

Sponsor

Radboud University Medical Center